The tech behind NZ mammogram software firm Volpara’s global success

The tech behind NZ mammogram software firm Volpara’s global success
Around 42% of mammograms in the US touch Volpara software, says CEO Teri Thomas. (Image: Volpara)
Ben Moore
Volpara Health has become a staple name in the medtech industry as a software provider to detect breast cancer in mammogram images.The company was founded in 2009, listed on the Australian securities exchange (ASX) in 2016 and since then has seen strong growth.Chief executive Teri Thomas said 42% of mammograms in the United States touch at least one of Volpara’s products.“We doubled the number of big healthcare organisation engagements in the United States over the last year … from 10 to 20, so we've had record growth and...

More Health

Minister's $200m tobacco tax cut bypasses Cabinet requirements
Policy

Minister's $200m tobacco tax cut bypasses Cabinet requirements

Researchers say there's more evidence to support the repealed Smokefree policies.

Jem Traylen 26 Jul 2024
Blood cancer clinical trials starting at Wellington Hospital
News in Brief

Blood cancer clinical trials starting at Wellington Hospital

The phase 2 trial will test the Malaghan Institute's groundbreaking therapy.

Staff reporters 25 Jul 2024
Commissioner replaces Te Whatu Ora’s board
Policy

Commissioner replaces Te Whatu Ora’s board

Lester Levy to be new health czar.

Jem Traylen 22 Jul 2024
Health NZ: fewer billion-dollar hospital projects, more staging
Infrastructure

Health NZ: fewer billion-dollar hospital projects, more staging

The centralised agency wants to change how NZ delivers health infrastructure.

Oliver Lewis 18 Jul 2024